Cliff Asness's LUCD Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 723,200 shares of Lucid Diagnostics Inc. (LUCD) worth $773,824, representing 0.00% of the portfolio. First purchased in 2025-Q3, this short-term holding has been held for 4 quarters.
Based on 13F filings, Cliff Asness has maintained this position in LUCD for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2026, adding 488,431 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Lucid Diagnostics (LUCD) Holding Value Over Time
Track share changes against reported price movement
Quarterly Lucid Diagnostics (LUCD) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +488,431 | Add 208.05% | 723,200 | $1.07 |
| Q1 2026 | +153,208 | Add 187.84% | 234,769 | $1.15 |
| Q4 2025 | +865 | Add 1.07% | 81,561 | $1.09 |
| Q3 2025 | +80,696 | New Buy | 80,696 | $1.01 |
Cliff Asness's Lucid Diagnostics Investment FAQs
Cliff Asness first purchased Lucid Diagnostics Inc. (LUCD) in Q3 2025, acquiring 80,696 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Lucid Diagnostics Inc. (LUCD) for 4 quarters since Q3 2025.
Cliff Asness's largest addition to Lucid Diagnostics Inc. (LUCD) was in Q2 2026, adding 723,200 shares worth $773,824.
According to the latest 13F filing for Q2 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 723,200 shares of Lucid Diagnostics Inc. (LUCD), valued at approximately $773,824.
As of the Q2 2026 filing, Lucid Diagnostics Inc. (LUCD) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Lucid Diagnostics Inc. (LUCD) was 723,200 shares, as reported at the end of Q2 2026.